Raymond James Financial, Inc. vs Revvity Inc — how do they compare? Raymond James Financial, Inc. trades at $167 (market cap $32.73B), while Revvity Inc trades at $110.67 (market cap $12.33B). The key difference: Raymond James Financial, Inc. is far larger — about 2.7× Revvity Inc's market cap, and Raymond James Financial, Inc. pays the higher dividend (1.29%). Which is the better fit depends on your goals.
| RJF | RVTY | |
|---|---|---|
Market Cap | $32.73B | $12.33B |
Sector | Financials | Technology |
52-Week High | $176.43 | $117.75 |
52-Week Low | $140.89 | $82.26 |
Dividend Yield | 1.29% | 0.25% |
Enterprise Value | — | $14.82B |
Trailing returns across standard periods
Latest headlines on both assets
Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →